Molecular alterations in sporadic breast cancer, Critical Reviews in Oncology/Hematology, vol.44, issue.2, pp.121-141, 2002. ,
DOI : 10.1016/S1040-8428(01)00191-3
Prognostic molecular markers in early breast cancer, Breast Cancer Research, vol.3, issue.3, pp.109-118, 2004. ,
DOI : 10.1038/nrc1043
Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1, JNCI Journal of the National Cancer Institute, vol.93, issue.12, pp.913-920, 2001. ,
DOI : 10.1093/jnci/93.12.913
Use of a cDNA microarray to analyse gene expression patterns in human cancer, Nat Genet, vol.14, pp.457-460, 1996. ,
DNA microarray and cancer, Current Opinion in Oncology, vol.15, issue.1, pp.36-43, 2003. ,
DOI : 10.1097/00001622-200301000-00005
Quantification of estrogen receptor ?? and ?? expression in sporadic breast cancer, Oncogene, vol.20, issue.56, pp.8109-8115, 2001. ,
DOI : 10.1038/sj.onc.1204917
The meaning and use of the area under a receiver operating characteristic (ROC) curve., Radiology, vol.143, issue.1, pp.29-36, 1982. ,
DOI : 10.1148/radiology.143.1.7063747
GeneANOVA--gene expression analysis of variance, Bioinformatics, vol.18, issue.3, pp.490-491, 2002. ,
DOI : 10.1093/bioinformatics/18.3.490
Nonparametric Estimation from Incomplete Observations, Journal of the American Statistical Association, vol.37, issue.282, pp.457-481, 1958. ,
DOI : 10.1214/aoms/1177731566
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples, British Journal of Cancer, vol.35, issue.1, pp.1-39, 1977. ,
DOI : 10.1038/bjc.1977.1
Regression Models and Life-Tables, J R Stat Soc (B), vol.34, pp.187-220, 1972. ,
DOI : 10.1007/978-1-4612-4380-9_37
family mRNA expression in breast carcinomas, International Journal of Cancer, vol.18, issue.5, pp.758-765, 2003. ,
DOI : 10.1002/ijc.11273
Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay, Cancer Res, vol.59, pp.2759-2765, 1999. ,
Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcriptionpolymerase chain reaction assay, Clin Cancer Res, vol.6, pp.452-459, 2000. ,
Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays, British Journal of Cancer, vol.12, issue.4, pp.580-586, 2002. ,
DOI : 10.1038/sj.bjc.6600109
Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy, Cancer Res, vol.61, pp.1652-1658, 2001. ,
Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene, Carcinogenesis, vol.22, issue.9, pp.1521-1526, 2001. ,
DOI : 10.1093/carcin/22.9.1521
Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas, Clin Cancer Res, vol.9, pp.4415-4422, 2003. ,
Prognostic value of uPA, PAI-1 and PAI-2 mRNA expression in primary breast cancer, Anticancer Res, vol.22, pp.2997-3003, 2002. ,
Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells, Cancer Res, vol.61, pp.5168-5178, 2001. ,
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proceedings of the National Academy of Sciences, vol.179, issue.1, pp.10869-10874, 2001. ,
DOI : 10.1002/(SICI)1096-9896(199605)179:1<31::AID-PATH523>3.0.CO;2-O
Predicting the clinical status of human breast cancer by using gene expression profiles, Proceedings of the National Academy of Sciences, vol.11, issue.1, pp.11462-11467, 2001. ,
DOI : 10.1016/0303-7207(96)03844-0
Gene expression profiles of poor-prognosis primary breast cancer correlate with survival, Human Molecular Genetics, vol.11, issue.8, pp.863-872, 2002. ,
DOI : 10.1093/hmg/11.8.863
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer, New England Journal of Medicine, vol.347, issue.25, pp.1999-2009, 2002. ,
DOI : 10.1056/NEJMoa021967
Gene expression predictors of breast cancer outcomes, The Lancet, vol.361, issue.9369, pp.1590-1596, 2003. ,
DOI : 10.1016/S0140-6736(03)13308-9
Associations between gene expressions in breast cancer and patient survival, Hum Genet, vol.111, pp.411-420, 2002. ,
Regulation of G1 cell-cycle progression by oncogenes and tumor suppressor genes, Current Opinion in Genetics & Development, vol.12, issue.1, pp.47-52, 2002. ,
DOI : 10.1016/S0959-437X(01)00263-5
Cyclin E immunoexpression in breast ductal carcinoma: Pathologic correlations and prognostic implications, Human Pathology, vol.32, issue.1, pp.89-94, 2001. ,
DOI : 10.1053/hupa.2001.21141
The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node, Oncogene, vol.21, issue.30, pp.4680-4690, 2002. ,
DOI : 10.1038/sj.onc.1205578
Cyclin E and Survival in Patients with Breast Cancer, New England Journal of Medicine, vol.347, issue.20, pp.1566-1575, 2002. ,
DOI : 10.1056/NEJMoa021153
Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer, Oncogene, vol.22, issue.31, pp.4898-4904, 2003. ,
DOI : 10.1038/sj.onc.1206818
Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells, Proceedings of the National Academy of Sciences, vol.88, issue.6, pp.13078-13083, 1996. ,
DOI : 10.1093/jnci/88.6.365
Cell cycle control of BRCA2, Cancer Res, vol.56, pp.4590-4594, 1996. ,
HighBRCA2 mRNA expression predicts poor prognosis in breast cancer patients, International Journal of Cancer, vol.73, issue.6, pp.879-882, 2002. ,
DOI : 10.1002/ijc.10231
The fundamental role of epigenetic events in cancer, Nat Rev Genet, vol.3, pp.415-428, 2002. ,